Headquartered in Else-krÖner-strasse 1, Bad Homburg Fiscal year ends December NYSE: FMS freseniusmedicalcare.com
Fresenius Medical Care provides products and services for people with renal disease. As of September 30, 2026, it treated 289,014 dialysis patients in 3,512 clinics worldwide and had 106,291 employees. The company reports three operating segments:
- **Care Delivery:** dialysis services in the U.S. and internationally.
- **Value-Based Care:** risk-based kidney care contracts with payors and CMS programs such as CKCC.
- **Care Enablement:** develops, manufactures and sells dialysis products, including dialysis machines such as the 5008X CAREsystem, dialyzers and acute kidney care systems such as multiFiltratePRO.
The company is executing the FME25+ transformation program and a portfolio optimization plan, including divestitures and a refined China strategy that exited local 4008A production and peritoneal dialysis. It is also rolling out high-volume hemodiafiltration (HvHDF) in the U.S. It is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS). Updated
An adjusted EPS beat of this size usually gets celebrated, but new CEO Shervin Korangy called management "muted in our assessment of performance" and narrowed full-year operating income guidance to the lower half of the prior range on fourth-quarter headwinds. Operating income fell 23% as the China exit and transformation costs hit reported numbers.
Warren Buffett is the world’s greatest investor. Since becoming chairman of Berkshire Hathaway (NYSE:BRK-A | BRK-A Price Prediction)(NYSE:BRK-B) in the mid-1960’s, he has generated annual average returns of almost 20%, or nearly…
Warren Buffett has obliterated the market’s returns since becoming CEO of Berkshire Hathaway (NYSE:BRK-A | BRK-A Price Prediction)(NYSE:BRK-B) in the mid-1960s. While the S&P 500 has a cumulative return of about 33,000%…
Friday's top analyst upgrades and downgrades included Activision Blizzard, Altria, AppLovin, Bumble, Cano Health, Hanesbrands, Okta, Palo Alto Networks, Redfin, RingCentral, Rivian Automotive, Roblox, Salesforce, SunPower, TJX Companies, Upstart and Viatris.
Tuesday's top analyst upgrades and downgrades included Atlassian, Autodesk, BioMarin Pharmaceutical, Darden Restaurants, DraftKings, eBay, Fortinet, LyondellBasell Industries, Riot Blockchain and WEC Energy.
Here is another look at Gap, Beyond Meat and other stocks that Wall Street analysts expected little from in the past week.
Monday's top analyst upgrades and downgrades included Chewy, Cloudflare, Coca-Cola, Doximity, Ideanomics, GlaxoSmithKline, Micron Technology, SoFi Technologies, Teladoc Health, Twitter and Walmart.
The top analyst upgrades, downgrades and initiations seen on Thursday included Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify, Western Digital and Whiting Petroleum.
The California state Assembly on Wednesday approved a bill that limits the amount dialysis centers can charge patients. The legislation, if passed by the Senate and signed by the governor, may preclude…
The top analyst upgrades, downgrades and initiations seen on Tuesday include Affimed, Coty, Cree, Lululemon Athletica, Myriad Genetics, Tesla and Xilinx.
The top analyst upgrades, downgrades and initiations seen on Friday include Apache, Chesapeake Energy, Goldman Sachs, Intuit, Yum China, Goodyear and Wayfair.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Gold Fields, Humana, Intel, PayPal and Yelp,
Stocks were indicated higher on Thursday, after gains on Tuesday and Wednesday were handy. Oil also crossed back above the $50 barrier again for the first time since October 2015. The notion…
The top analyst calls for Tuesday, January 5, 2016, include Anadarko, CSC, DuPont, First Solar, Halliburton, Mattel, Priceline and Starbucks.
We ran a screen searching for Bank of America Merrill Lynch Buy-rated Japanese and European-listed American depositary shares that have at least 20% of sales in North America.
These are the top analyst upgrades, downgrades and initiations from Wall Street analysts for Tuesday, August 5, 2014. They include Himax Technologies, Ocwen Financial, RetailMeNot and Tenet Healthcare.
Fresenius Medical Care provides products and services for people with renal disease. As of September 30, 2026, it treated 289,014 dialysis patients in 3,512 clinics worldwide and had 106,291 employees.
24/7 Wall St.'s 12-month price target for FMS is $30.98, rated Buy. The Wall Street consensus target is $22.80. FMS price prediction →
